Company intelligence / Profile preview

Zejing Pharmaceutical

Shaoxing, Zhejiang, Chinaen.jiuzhoupharma.com ↗

Ownership: Private
Employees: ~6800
Development stage: Commercial

Overview

Zhejiang Medicine is a large-scale, publicly listed pharmaceutical company with several approved and marketed products (notably vitamins, antibiotics, and anti-infectives). Its pipeline includes small molecule drugs, antibody-drug conjugates, and biological products, with programs spanning from Phase 1 to commercial/approved stages, particularly in anti-infectives and oncology. Injectable antibiotics like vancomycin hydrochloride and teicoplanin have dominant market positions in China, and the company maintains global supply for several key products.[1][7][8]

Therapeutic areas: Infectious DiseasesOncologyPulmonology
Modalities: Small moleculeBiologicAntibody-drug conjugateAntibioticPeptide
Industry: Pharma

Beyond the preview

Go deeper on Zejing Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zejing Pharmaceutical.

Explore the full profile